An earlier report demonstrated that BCL2A1 was more highly expressed in advanced breast cancers compared to less-advanced cancers in clinical situations, implying that BCL2A1 expression could be a poor prognostic factor [19]. The gene discussed is BCL2A1; the disease is breast cancer.